Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyang Liu

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Medicine|September 29, 2025
Pear phytobezoar as a rare cause of small bowel obstruction: a case reportKuanyong Yu, Wenjun Feng, Liyang Liu, et al.
Frontiers in Immunology|May 27, 2022
The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization StudyDi He, Liyang Liu, Dongchao Shen, et al.
Experimental and Therapeutic Medicine|October 2, 2019
Acute multiple cerebral infarction combined with cerebral microhemorrhage in Polycythemia vera: A case reportNan Wang, Liyang Liu, Xin Jiang, et al.
Frontiers in Endocrinology|January 29, 2026
Predictive value of thyroid hormone levels for postpartum hemorrhage in hypothyroidism-complicated pregnancyYulu Zhu, Liyang Liu, Cheng Wang, et al.
Life Sciences|June 16, 2026
Development of a short-term mouse model of early MASLD for non-invasive pathophysiological tracking via urinary metabolomics and micro-CTLu Yu, Liping Wang, Fangchao Hu, et al.
Chemical Communications (Cambridge, England)|February 5, 2016
Selectivity of CO2 via pore space partition in zeolitic boron imidazolate frameworksHai-Xia Zhang, Min Liu, Guilan Xu, et al.
Nature Communications|February 8, 2025
Modeling and designing enhancers by introducing and harnessing transcription factor binding unitsJiaqi Li, Pengcheng Zhang, Xi Xi, et al.
Oncotarget|December 2, 2017
Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysisLiyang Liu, Jianfei Wen, Xi Gu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 12, 2013
Vitexicarpin acts as a novel angiogenesis inhibitor and its target networkBo Zhang, Lu Liu, Shiwen Zhao, et al.
Biomed Research International|June 30, 2020
Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder CarcinomaLiyang Liu, Xiaodan Zhong, Haining Cui, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|September 29, 2025
Pear phytobezoar as a rare cause of small bowel obstruction: a case reportKuanyong Yu, Wenjun Feng, Liyang Liu, et al.
Frontiers in Immunology|May 27, 2022
The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization StudyDi He, Liyang Liu, Dongchao Shen, et al.
Experimental and Therapeutic Medicine|October 2, 2019
Acute multiple cerebral infarction combined with cerebral microhemorrhage in Polycythemia vera: A case reportNan Wang, Liyang Liu, Xin Jiang, et al.
Frontiers in Endocrinology|January 29, 2026
Predictive value of thyroid hormone levels for postpartum hemorrhage in hypothyroidism-complicated pregnancyYulu Zhu, Liyang Liu, Cheng Wang, et al.
Life Sciences|June 16, 2026
Development of a short-term mouse model of early MASLD for non-invasive pathophysiological tracking via urinary metabolomics and micro-CTLu Yu, Liping Wang, Fangchao Hu, et al.
Chemical Communications (Cambridge, England)|February 5, 2016
Selectivity of CO2 via pore space partition in zeolitic boron imidazolate frameworksHai-Xia Zhang, Min Liu, Guilan Xu, et al.
Nature Communications|February 8, 2025
Modeling and designing enhancers by introducing and harnessing transcription factor binding unitsJiaqi Li, Pengcheng Zhang, Xi Xi, et al.
Oncotarget|December 2, 2017
Prognostic role of long non-coding RNA LINC00152 in Chinese cancer patients: a meta-analysisLiyang Liu, Jianfei Wen, Xi Gu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 12, 2013
Vitexicarpin acts as a novel angiogenesis inhibitor and its target networkBo Zhang, Lu Liu, Shiwen Zhao, et al.
Biomed Research International|June 30, 2020
Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder CarcinomaLiyang Liu, Xiaodan Zhong, Haining Cui, et al.
Pageof 9